1 Nishino I, Fu J, Tanji K et al. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature 2000; 406: 906–10. 2 D’souza RS, Levandowski C, Slavov… Click to show full abstract
1 Nishino I, Fu J, Tanji K et al. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature 2000; 406: 906–10. 2 D’souza RS, Levandowski C, Slavov D et al. Danon disease: Clinical features, evaluation, and management. Cir. Heart Fail. 2014; 7: 843–9. 3 Hashem SI, Perry CN, Bauer M et al. Brief report: oxidative stress mediates cardiomyocyte apoptosis in a human model of Danon disease and heart failure. Stem Cells 2015; 33: 2343– 50. 4 Hayashi T, Tanimoto K, Hirayama-Yamada K et al. Genetic background of Japanese patients with pediatric hypertrophic and restrictive cardiomyopathy. J. Hum. Genet. 2018; 63: 989– 96. 5 Boucek D, Jirikowic J, Taylor M. Natural history of Danon disease. Genet. Med. 2011; 13: 563–8.
               
Click one of the above tabs to view related content.